TABLE 1.
Demographic and Medical Background
| HPI-Child | HPI-Child-Parent | Standard Care | Total | P | |
|---|---|---|---|---|---|
| Age (M = 12.8, SD = 3.9), y, % | |||||
| 6–12 | 46.6 | 48.2 | 52.6 | 49.1 | .79 NS |
| >12 | 53.4 | 51.8 | 47.4 | 50.9 | |
| Gender | |||||
| Male, % | 67.2 | 55.4 | 52.9 | 59.1 | .24 NS |
| Race/Ethnicity, % | |||||
| White | 70.7 | 72.3 | 70.2 | 70.7 | .61 NS |
| Black | 16.5 | 14.3 | 12.3 | 14.6 | |
| Hispanic | 5.2 | 3.6 | 7.0 | 5.3 | |
| Asian | 3.4 | 7.1 | 1.8 | 4.1 | |
| Other/Unknown | 5.1 | 1.8 | 8.8 | 5.3 | |
| Socioeconomic statusa | |||||
| I | 17.2 | 17.9 | 14.0 | 16.4 | .78 NS |
| II | 39.6 | 33.9 | 35.0 | 36.2 | |
| III | 20.7 | 25.0 | 14.0 | 19.8 | |
| IV & V | 15.5 | 12.5 | 22.8 | 16.9 | |
| Unknown | 6.9 | 10.7 | 14.0 | 10.5 | |
| Resident parent | |||||
| Mother | 84.7 | 85.7 | 76.7 | 82.4 | .46 NS |
| Father | 10.2 | 8.9 | 16.1 | 11.7 | |
| Other | 5.1 | 5.4 | 7.1 | 5.8 | |
| Site | |||||
| St Jude | 46.6 | 36.8 | 38.3 | 41.5 | .33 NS |
| HSC-Toronto | 15.5 | 26.1 | 31.6 | 23.9 | |
| CHOP | 24.1 | 19.6 | 19.3 | 20.5 | |
| NCH-Columbus | 13.8 | 17.5 | 10.7 | 14.0 | |
| Type of transplant | |||||
| Autologous | 10.3 | 21.4 | 24.1 | 18.1 | .35 NS |
| Allogeneic-matched sib | 27.6 | 26.8 | 22.8 | 25.7 | |
| Allogeneic-other | 62.1 | 51.8 | 52.6 | 56.1 | |
| Diagnostic group | |||||
| ALL | 27.1 | 26.8 | 26.3 | 26.9 | .98 NS |
| AML | 23.7 | 21.4 | 28.6 | 24.6 | |
| Other leukemia | 10.8 | 17.9 | 12.5 | 13.5 | |
| HD/NHL | 13.6 | 8.9 | 8.7 | 10.5 | |
| Solid tumor | 12.2 | 12.5 | 12.5 | 12.3 | |
| Nonmalignancy | 12.2 | 12.5 | 10.7 | 11.1 |
ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; CHOP, Children’s Hospital of Philadelphia; HD, Hodgkin disease; HPI, health promotion intervention; HSC, Hospital for Sick Children; NCH, Nationwide Children’s Hospital; NHL, non-Hodgkin lymphoma; NS, not significant.
a
Hollingshead 4-factor index classes I–V.